The presence of a polymorphic background with scattered HRS cells should prompt the diagnosis of CHL, whose neoplastic cells have a typical CD79a-/CD20-/CD45(LCA)-/PAX5+ weak/CD15+/-/CD30+/OCT2-/BOB1-phenotype. The gene discussed is PTPRC; the disease is classic Hodgkin lymphoma.